1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

AML - 1079

Pretransplant Measurable Residual Disease and Survival After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: Does Donor Type Change the Risk?

Preview of Pretransplant Measurable Residual Disease and Survival After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: Does Donor Type Change the Risk?

View Poster Contact Presenter

Poster Presenter

Aakriti Adhikari

Authors

Aakriti Adhikari

Part of Topic

Acute Myeloid Leukemia (AML)

AML, measurable residual disease, allogeneic hematopoietic cell transplantation, donor selection, survival outcomes

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.